Skip to content
Review Open access

Dynamic trajectories of inflammatory biomarkers and post-stroke cognitive impairment: a comprehensive review of neuroimmune mechanisms, longitudinal modeling, and clinical translation

Aug 2026 · Frontiers in Neurology · Vol 17 · 0 citations · 127 references
Medicine

TL;DR

Trajectory-based modeling, including latent class approaches and machine learning, may improve PSCI risk stratification and support personalized follow-up and anti-inflammatory prevention trials.

Abstract

Post-stroke cognitive impairment (PSCI) affects 30–50% of acute ischemic stroke survivors within the first year, yet the prognostic relevance of dynamic inflammatory trajectories remains incompletely defined. This narrative review synthesizes clinical and mechanistic evidence linking temporally evolving inflammatory biomarkers to vascular cognitive impairment after acute ischemic stroke. A structured evidence search of PubMed, MEDLINE, Embase, and Google Scholar from database inception to June 2026 prioritized longitudinal inflammatory-biomarker cohorts, trajectory-modeling analyses, machine-learning prediction studies, and mechanistic literature on neuroimmune injury. The available evidence indicates that post-stroke inflammation follows a multiphasic course, including hyperacute activation, acute peaking, subacute resolution, and, in a subset of patients, persistent low-grade inflammation. Delayed resolution or persistent elevation of interleukin-6, C-reactive protein, and the neutrophil-to-lymphocyte ratio appears to predict PSCI more accurately than single admission measurements. Mechanistically, sustained inflammatory signaling may contribute to chronic microglial activation, mCRP/VE-cadherin-mediated blood–brain barrier disruption, hippocampal and Papez-circuit vulnerability, and secondary neurodegeneration. Trajectory-based modeling, including latent class approaches and machine learning, may therefore improve PSCI risk stratification and support personalized follow-up and anti-inflammatory prevention trials. Larger prospective cohorts with standardized sampling and cognitive assessment are required to validate these translational applications.

Read PDF

Similar papers

Open access Sep 2026

Serial immune-inflammatory recovery trajectories after acute ischemic stroke: associations with early neurological deterioration and 90-day functional outcome in a retrospective cohort

Background Systemic inflammation after acute ischemic stroke is usually assessed using admission biomarkers, which may not distinguish transient stress from sustained immune-inflammatory activation. We examined whether serial immune-inflammatory recovery trajectories were associated with early neurological deterioratio...

Rui-Han Ni, Lan Chu · 0 citations
Review Open access Sep 2026

Clinical Utility of Circulating Biomarkers for Diagnosis and Prognosis of Acute Stroke in the Emergency Department: A Narrative Review from Current Evidence to Clinical Implementation

Circulating biomarkers are most likely to be useful as adjuncts to established stroke assessment, and integrated strategies, point-of-care platforms, and integration with clinical scales, neuroimaging, and artificial intelligence may require standardization, multicenter validation, and demonstration of additional clini...

Mihaela Marin, George Țocu, Lavinia Țocu et al. · 0 citations
Open access Sep 2026

Stroke severity–dependent prognostic value of the C-reactive protein–triglyceride glucose index after acute ischemic stroke

Functional outcomes after acute ischemic stroke vary substantially among patients with similar neurological deficit severity, suggesting that factors beyond acute injury burden contribute to recovery. Metabolic–inflammatory dysregulation represents a chronic host condition that may influence the poststroke recove...

Lin-Lin Ma, Lang Ji, Chuan-Jie Wu et al. · 0 citations
Open access Oct 2026

A clinical and biomarker model for predicting post-stroke cognitive impairment: a prospective cohort study

Background and objectives Post-stroke cognitive impairment (PSCI) is highly prevalent and substantially compromises functional recovery and quality of life; however, early identification remains challenging. This study aimed to develop and validate an early prediction model for PSCI by integrating routinely available b...

Xin-Yu Zhang, Xiang-Wen Hao, Yan-Yang Li et al. · 0 citations
Meta-analysis Open access Sep 2026

Diagnostic accuracy of circulating blood biomarker families in acute ischemic stroke: a secondary grouped meta-analysis with primary-study verification

The original analysis was revised as a transparent secondary grouped diagnostic accuracy meta-analysis and verified all contributing primary reports, and non-coding RNA and extracellular chromatin/cell-free DNA tests show promising but methodologically fragile diagnostic signals.

Xiao Luo, Long-Feng Ran, Ya-Ou Wu et al. · 0 citations
Review Open access Oct 2026

Cardiovascular Risk Factors and Biomarkers in the Prediction of Cognitive Decline in Older Adults—A Narrative Review

Background: Cognitive decline is a major health concern in older adults and results from a complex interaction between neurodegenerative, vascular, metabolic and inflammatory processes. Cardiovascular and metabolic risk factors may contribute to cognitive impairment through mechanisms including endothelial dysfunction,...

Diana-Gabriela Constantinescu, A. Ilie, Ramona Ștefăniu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.